Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/26/15 → 10/26/20 |
Funding
- Intercept Pharmaceuticals, Inc. (Prot # 747-302)
Prot#747-302: A Phase 3b, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Subjects with Primary Biliary Cirrhosis
- Flamm, Steven L (PD/PI)
Project: Research project